| Page | ||
|---|---|---|
| Charity information | ||
| Report ofthe Trustees | 2 —4 | |
| Independent Auditors' |
report | 5 —7 |
| Statement offinancial | activities | |
| Balance sheet | ||
| Statement ofcash flows | 10 | |
| Notes to the financial | statements | 11—17 |
| Trustees | Carl Graham FCA | ||
|---|---|---|---|
| Dr Baboo Kabra | |||
| Registered | Office | Wellesley House | |
| Duke ofWellington | Avenue | ||
| Royal Arsenal | |||
| London SE186SS | |||
| Accountants | Simpson Wreford LLP | ||
| Wellesley House | |||
| Duke ofWellington | Avenue | ||
| Royal Arsenal | |||
| London SE186SS | |||
| Auditors | DCP Accountants | LLP | |
| 457 Southchurch Road |
|||
| Southend-on-Sea | |||
| Essex SS12PH | |||
| Bankers | Barclays Bank PLC | ||
| 54 Lombard Street | |||
| London EC3P 3AH | |||
| Investment | Advisers | JMFinn and Co | |
| 4 Coleman Street | |||
| London EC2R 5TA |
| Notes | 2021 | 2020 | |
|---|---|---|---|
| INCOME AND ENDOWMENTS | |||
| Income from investments | 202,255 | 254,734 | |
| Total income | 202,255 | 254,734 | |
| EXPENDITURE | |||
| Expenditure on raising funds: |
|||
| Investment management |
costs | (13,247) | (14,941) |
| Expenditure on charitable |
activities | (206,032) | (232,876) |
| Total expenditure | (219,279) | (247,817) | |
| Net (expenditure)/income | before gains and losses | ||
| on investments | (17,024) | 6,917 | |
| Net gains/(losses) on investments |
752,106 | (904,680) | |
| Net movement in funds |
735,082 | (897,763) | |
| Total funds brought forward | 4,021,570 | 4,919,333 | |
| Total funds carried forward | 4,756,652 | 4,021,570 |
| AS AT31 | MARCH | 2021 | ||||
|---|---|---|---|---|---|---|
| Notes | 2021 | 2020 | ||||
| FIXED ASSETS | ||||||
| Investments | 4,681,808 | 3,990,259 | ||||
| CURRENT | ASSETS | |||||
| Debtors | 9 | 2,846 | 5,213 | |||
| Cash at bank | and in hand | 78,718 | 32,818 | |||
| 81,564 | 38.031 | |||||
| CREDITORS | ||||||
| Amounts due |
within one year | 10 | (6,720) | (6,720) | ||
| NET CURRENT ASSETS | 74,844 | 31,311 | ||||
| NET ASSETS | 4,756,652 | 4,021,570 | ||||
| FUNDS | ||||||
| Unrestricted | fund | 13 | 4,756,652 | 4,021,570 |
| FOR THE Y | EA | R ENDED | 31MARCH 202 | 1 |
|---|---|---|---|---|
| Notes | 2021 | 2020 | ||
| Net cash used in operating activities |
12 | (216,911) | (247837) | |
| Cashflows frominvesting activities: |
||||
| Interest and dividends | 202,255 | 254,734 | ||
| Proceeds from sale ofinvestments | 504,742 | 828,168 | ||
| Purchase ofinvestments | (444,186) | (824,428) | ||
| Net cash provided by investing activities |
262,811 | 258874 | ||
| Change in cash and cash equivalents | in | the year | 45,900 | 10,637 |
| Cash and cash equivalent brought forward |
32,818 | 22,181 | ||
| Cash and cash equivalents carried forward |
78,718 | 32418 |
| 3. | INCOME F | ROM IN | VES | TMENT | S | ||
|---|---|---|---|---|---|---|---|
| 2021 | 2020 | ||||||
| g | |||||||
| UK dividends | 197,480 | 246,815 | |||||
| Dividends from outside |
ofthe UK | 4,750 | 7,887 | ||||
| Interest received | 25 | 32 | |||||
| 202,255 | 254,734 | ||||||
| 4. | INVESTMENT MANAGEMENT | COSTS | |||||
| 2021 | 2020 | ||||||
| g | g | ||||||
| Stockbroker | administrative | charges | 13,247 | 14,941 | |||
| 13,247 | 14,941 | ||||||
| 5. | EXPENDITURE ON | CHARITABLE ACTIVITIES | |||||
| 2021 | 2020 | ||||||
| g | |||||||
| Accountancy | and trust | management | 12,480 | 12,480 | |||
| Auditor remuneration | —note 6 | 3,600 | 3,600 | ||||
| Legal and professional | fees | 3,000 | |||||
| Grants issued | —note 7 | 186,952 | 216,796 | ||||
| 206,032 | 232,876 | ||||||
| 6. | AUDITOR REMUNERATION | ||||||
| 2021 | 2020 | ||||||
| g | g | ||||||
| Auditor remuneration | —audit fee | 3,600 | 3,600 | ||||
| 3,600 | 3,600 |
| ANALYSIS OF GRANTS | ||
|---|---|---|
| 2021 | 2020 | |
| Grants to Institutions: | ||
| StRaphael's Hospice |
35,000 | 45,000 |
| Trinity Hospice —Psychiatrist | 26,151 | 26,150 |
| Trinity Hospice —Registrar |
10,049 | 10,049 |
| Bowel Cancer | 15,000 | 15,000 |
| Marie Curie | 22,500 | 30,000 |
| SW Thames Kidney Fund | 15,252 | 18,597 |
| Prostate Cancer | 20,000 | 20,000 |
| Teenage Cancer Trust | 6,000 | |
| Action Medical Research | 10,000 | 10,000 |
| Stroke Association | 20,000 | 20,000 |
| Maggie Keswick Jencks Cancer Caring Centre | 10,000 | 10,000 |
| 183,952 | 210,796 | |
| Grants to Individuals: | 3,000 | 6,000 |
| Total grants issued | 186,952 | 216,796 |
| INVESTMENTS | ||
|---|---|---|
| 2021 | 2020 | |
| f. | ||
| Balance brought forward |
3,990,259 | 4,$98,679 |
| Additions at cost |
444,186 | 824,428 |
| Disposal proceeds | (504,742) | (828,168) |
| Realised (loss)/gain | 45,599 | 16,588 |
| Unrealised (loss)/gain |
706,506 | (921,268) |
| Balance carried forward | 4,681,$08 | 3,990,259 |
| Market Value (K) | Market Value (K) | |||
|---|---|---|---|---|
| 2021 | 2020 | |||
| Australia: | ||||
| National | Australia Bank | 64,483 | 37,007 | |
| Sweden: | ||||
| Svenska | Handelsbanken | 51,208 | 43,997 | |
| Germany: | ||||
| Siemens | 89,342 | 50,699 | ||
| 9. | DEBTORS | |||
| 2021 | 2020 | |||
| Accrued | income | 2,846 | 5,213 |
| CREDITORS | ||
|---|---|---|
| 2021 | 2020 | |
| Accruals | 6,720 | 6,720 |
| FROM OPERATING AC | T | IVITIES | ||
|---|---|---|---|---|
| 2021 | 2020 | |||
| g | ||||
| Net movement in funds |
735,082 | (897,763) | ||
| Deduct interest and dividend | income shown | (202,255) | (254,734) | |
| in investing activities |
||||
| Deduct gains/add back losses |
on investments | (752,105) | 904,680 | |
| Decrease/(increase) in debtors |
2,367 | (20) | ||
| Net cash used in operating | activities | (216,911) | (247,837) | |
| FUND MOVEMENT | ||||
| Unrestricted | ||||
| Balance at 1 April 2020 | 4,021,570 | |||
| Movement for the year |
735,082 | |||
| Balance at 31March 2021 | 4,756,652 |